HealthTab™ Enters Multi-Year Collaboration Agreement with Abbott for Point-of-Care Testing Across the UK
Article excerpt
Highlighted: the sentence this signal was extracted from
VANCOUVER, British Columbia, Aug. 20, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) is pleased to announce that its wholly-owned subsidiary, HealthTab Ltd, has entered into a formal collaboration agreement with Abbott, a global healthcare company, to supply and distribute Abbott's point-of-care testing products through the HealthTab™ platform in the UK. The agreement allows HealthTab to distribute Abbott's Afinion™ 2 Analyzer in NHS-linked pharmacies to test for HbA1c and lipid profiles. The collaboration also establishes a structured framework for the continued expansion of point-of-care testing through community pharmacies. "This agreement represents our most significant milestone to date," said Rodger Seccombe, CEO of Avricore Health. "We've spent fifteen years building and proving the model for pharmacy-based point-of-care testing, and we've learned that solving this problem takes more than great technology - it takes an industry-leading partner willing to invest the people, expertise, and resources needed to make it successful. We couldn't have asked for a better team to be working with, and together we're going to make a real impact on patient care." HealthTab™ at the Core of Scalable, Integrated PoCT HealthTab™ provides a complete, turnkey solution underpinning national pharmacy-based PoCT networks, including best-in-class instruments, consumables...
Keep reading with a free account
The rest of this article, and every signal for Abbott, is in your free account.